Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1Breast 1

Conditions

Melanoma 1Lung Neoplasms 1Glioma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Interleukin-2 3pazopanib 2lenvatinib 2aldesleukin 2Nivolumab 2Nephrectomy 2Metastasectomy 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Fluorodeoxyglucose F18 2Cryosurgery 2Biopsy 2tremelimumab 1spartalizumab 1pembrolizumab 1gallium 68 PSMA-11 1enzalutamide 1denileukin diftitox 1daratumumab 1clevudine 1canakinumab 1cabozantinib 1Sorafenib 1Microscopy, Electron 1Isoflavones 1Immunoglobulin G 1Genistein 1FS 069 1FAPI-46 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Renal Cell × clevudine × Clear all
NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

University of Southern California

Phase EARLY_PHASE1 Completed
10 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡